FdaApplication
NDA 214018
Identifiers
- fda_app_no: NDA214018
Properties
| Property | Value |
|---|---|
| applicant_name | SENTYNL THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2021-02-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NULIBRY | FOSDENOPTERIN HYDROBROMIDE | EQ 9.5MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product